In Sub-Saharan Africa, 96% of sickle cell patients are undiagnosed and 20% of them do not reach the age of six.
With the collaboration between digital start-up Hemex and Novartis’ Biome a big step has been taken to fundamentally change this tragedy.
Collaboration is key to success, especially when it comes to combining healthcare in developing countries with data and digital. Novartis is fully aware of this. Even start-up Hemex was surprised at the speed at which Novartis was driving its sickle cell disease project in Ghana.